Survival Benefit of Long-Term Sorafenib Treatment in Patients with Advanced Hepatocellular Carcinoma in Indonesia: Multicenter experience

被引：0
|
作者：
Lesmana, Cosmas R. [1 ,2 ]
Gani, Rino A. [1 ]
Pakasi, Levina S. [2 ]
Hasan, Irsan [1 ]
Waspodo, Agus S. [3 ]
Siregar, Lianda [3 ]
Budi, Poernomo [4 ]
Lesmana, Laurentius A. [1 ,2 ]
机构：
[1] Cipto Mangunkusumo Hosp, Jakarta, Indonesia
[2] Medistra Hosp, Digest Dis & GI Oncol Ctr, Jakarta, Indonesia
[3] Dharmais Canc Ctr Hosp, Jakarta, Indonesia
[4] Dr Soetomo Hosp, Surabaya, Indonesia
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1389
引用
收藏
页码：866A / 867A
页数：2
相关论文
共 50 条
  • [41] Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic review
    Zhang, Xin
    Yang, Xin-Rong
    Huang, Xiao-Wu
    Wang, Wei-Min
    Shi, Ruo-Yu
    Xu, Yang
    Wang, Zheng
    Qiu, Shuang-Jian
    Fan, Jia
    Zhou, Jian
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (05) : 458 - 466
  • [42] SORAFENIB FOR THE TREATMENT OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS
    Giovanis, P.
    Vincenzi, V.
    Manuppelli, C.
    Berletti, R.
    Ricagna, F.
    Giusto, M.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S246 - S247
  • [43] Benefit-Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on Sorafenib
    Pelosof, Lorraine
    Lemery, Steven
    Casak, Sandra
    Jiang, Xiaoping
    Rodriguez, Lisa
    Pierre, Vadryn
    Bi, Youwei
    Liu, Jiang
    Zirkelbach, Jeanne Fourie
    Patel, Anuja
    Goldberg, Kirsten B.
    McKee, Amy E.
    Keegan, Patricia
    Pazdur, Richard
    ONCOLOGIST, 2018, 23 (04): : 496 - 500
  • [44] Sorafenib in treatment of patients with advanced hepatocellular carcinoma:a systematic review
    Xin Zhang
    Hepatobiliary&PancreaticDiseasesInternational, 2012, 11 (05) : 458 - 466
  • [45] A statistical model for survival risk prediction in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
    Berhane, S.
    Fox, R.
    Chan, S. L.
    Yau, T.
    Johnson, P.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S197 - S198
  • [46] Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
    Stras, Wojciech
    Gotlib, Joanna
    Malkowski, Piotr
    Wasiak, Dariusz
    Sliwczynski, Andrzej
    Panczyk, Mariusz
    Tronina, Olga
    Brzozowska, Melania
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [47] Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
    Abdel-Rahman, Omar
    Abdelwahab, Manal
    Shaker, Mohammed
    Abdelwahab, Sherif
    Elbassiony, Mohammed
    Ellithy, Mahmoud
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (01) : 9 - 13
  • [48] Liver Transplantation in Patients With Hepatocellular Carcinoma: Long-Term Survival Results
    Mohamed Chairi, Mohamed Hassin
    Mogollon Gonzalez, Monica
    Perez Alonso, Alejandro Jose
    Dominguez Bastante, Mireia
    Herrero Torres, Maria De Los Angles
    Acosta Gallardo, Carmen
    Palomeque Jimenez, Antonio
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (01) : 48 - 50
  • [49] Long-Term Survival After Surveillance and Treatment in Patients with Chronic Viral Hepatitis and Hepatocellular Carcinoma
    Tong, Myron J.
    Rosinski, Alexander A.
    Huynh, Claiborne T.
    Raman, Steven S.
    Lu, David S. K.
    HEPATOLOGY COMMUNICATIONS, 2017, 1 (07) : 595 - 608
  • [50] EMERGENCE OF ADVERSE CARDIOVASCULAR EVENTS AFTER LONG TERM SORAFENIB TREATMENT FOR ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
    Elisa Reig, Maria
    Forner, Alejandro
    Rodriguez de Lope, Carlos
    Rimola, Jordi
    Ayuso, Carmen
    Mestres, Carlos A.
    Llovet, Josep M.
    Bruix, Jordi
    HEPATOLOGY, 2009, 50 (04) : 1080A - 1081A
12345